WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Now Available: The U.S. Dredge Report — download today for expert dredging market insights and data → Click Here

Workboat Indexes

My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers NUTX
ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers JSPR
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers LNTH
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fiserv
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers FI
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Charter Communications
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers CHTR
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers ALT
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers NUTX
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers UNCY
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers SMLR
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers SLQT
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quantum
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers QMCO
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PubMatic
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers PUBM
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lockheed Martin
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers LMT
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers LFMD
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Flywire
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers FLYW
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers REPL
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tronox
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers TROX
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers RXST
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers SVRA
URBANICA Furniture Brings Premium Ergonomic Office Solutions Direct to Consumers at Up to 50% Savings
From URBANICA
Via GlobeNewswire
Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Tickers TEVA
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Tickers TEVA
Unicoin Announcement: If You Have Suffered Losses in Unicoin Rights Certificates Issued by Unicoin, Inc. f/k/a TransparentBusiness, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SLNO
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers DHR
Wiingy Report: Trump’s $100,000 H1B Visa Fee Opens Over Half a Million Tech Jobs to Americans
From Wiingy Inc.
Via GlobeNewswire
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
From C4 Therapeutics, Inc.
Via GlobeNewswire
Tickers CCCC
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers TLX
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SVRA
ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SMLR
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2025 Diversified Communications. All rights reserved.